There are indications that a simple finger-prick blood test could, in the future, detect Alzheimer’s disease long before the first clinical symptoms become apparent. This is shown by research conducted by the European PREDICTOM consortium, in which UZ Brussels and the Vrije Universiteit Brussel (VUB) are partners. This approach could offer a more accessible and less burdensome alternative to the current, complex diagnostic methods.

Dan Bessesen, MD, a health and wellness leader at CU Anschutz, offers key insights on weight loss drugs, particularly compounded GLP-1s that are banned by the FDA but continue to be available.

New UBC research examines how clinicians assess eligibility for Track 2 medical assistance in dying and identifies system-level barriers affecting access and decision-making.

A new app, called JawSpace®, launches the world’s first digital medical device dedicated to empowering and supporting people living with Temporomandibular Disorders (TMD), combining practical self-management guidance together with the latest scientific research from Newcastle University, UK.